Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012-2013.
Retinal periphlebitis is associated with multiple sclerosis severity.
Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.
Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.
Variability in the CIITA gene interacts with HLA in multiple sclerosis.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.
On the role of physiological fluctuations in quantitative gradient echo MRI: implications for GEPCI, QSM, and SWI.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: economic evaluation of a randomised controlled trial.
Update in pediatric optic neuritis.
Intracortical Posterior Cingulate Myelin Content Relates to Error Processing: Results from T1- and T2-Weighted MRI Myelin Mapping and Electrophysiology in Healthy Adults.
A novel model of demyelination and remyelination in a GFP-transgenic zebrafish.
Use of a physiological profile to document motor impairment in ageing and in clinical groups.
Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis.
Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.
Proteinticle Engineering for Accurate 3D Diagnosis.
Episodic Mood Changes Preceding an Exacerbation of Multiple Sclerosis.
Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
415
416
417
418
419
420
421
422
423
…
next ›
last »